Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Meningioma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Meningioma to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Meningioma Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Meningioma Therapeutics, Global, Clinical Trials by Region, 2017* 6
Meningioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Meningioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Meningioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 9
Meningioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Meningioma Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Meningioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 12
Proportion of Meningioma to Oncology Clinical Trials, G7 Countries (%), 2017* 13
Meningioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Meningioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Meningioma to Oncology Clinical Trials, E7 Countries (%), 2017* 16
Meningioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Meningioma Therapeutics, Global, Clinical Trials by Phase, 2017* 18
Meningioma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 19
Meningioma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Meningioma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Meningioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Meningioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
Meningioma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Meningioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Meningioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26

List of Figures
Meningioma Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Meningioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Meningioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Meningioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 9
Meningioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Meningioma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Meningioma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 12
Proportion of Meningioma to Oncology Clinical Trials, G7 Countries (%), 2017* 13
Meningioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Meningioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Meningioma to Oncology Clinical Trials, E7 Countries (%), 2017* 16
Meningioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Meningioma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
Meningioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 19
Meningioma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Meningioma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Meningioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Meningioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
Meningioma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Meningioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Meningioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
GlobalData Methodology 78

Companies Mentioned
- Novartis AG
- F. Hoffmann-La Roche Ltd
- C. H. Boehringer Sohn AG & Co KG
- Pfizer Inc
- AstraZeneca Plc
- e-Therapeutics Plc
- Celgene Corp
- Burzynski Research Institute Inc
- Arno Therapeutics Inc
- AbbVie Inc